MarketCap
Facebook
X
Telegram
Zimmer Biomet Holdings Balance Sheet 2025-2006 | ZBH
Brief overview of Zimmer Biomet Holdings's financial position
The balance sheet is assessed across five available annual reports spanning 2021 to 2025.
The size of the balance sheet remained broadly stable, moving from $23.5 billion to $23.1 billion. There was no meaningful expansion.
Assets and liabilities changed at similar rates, -1.6% and -3.7%. The funding mix did not shift sharply.
Internal capital represents 55% of the balance sheet, previously 54%. This is a strong capital position.
Each unit of equity supports about 0.5x of net debt. Dependence on debt remains comfortable.
Cash represents 2.6% of assets versus 1.6% initially, showing how the immediate liquidity reserve changed.
Accumulated earnings ended at $11.6 billion, a change of +12.8%. They remain an important part of the capital base.
What the balance sheet shows
Zimmer Biomet Holdings retains a reasonably healthy balance sheet structure, which still needs support from earnings and cash flow.
Annual Balance Sheet Zimmer Biomet Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
6.4 B | 4.87 B | 4.5 B | 4.83 B | 679 M | -727 M | 7.6 B | 8.38 B | 9.6 B | 10.6 B | 10.1 B | 318 M | 583 M | 903 M | 951 M | 473 M | 436 M | 248 M | - | - |
Long Term Debt |
6.93 B | 5.34 B | 4.87 B | 5.15 B | 1 B | 500 K | 6.72 B | 8.4 B | 8.89 B | 10.6 B | 11.5 B | 1.4 B | 1.66 B | 1.69 B | 1.58 B | 1.14 B | 1.13 B | 460 M | - | - |
Long Term Debt Current |
57.5 M | 53.2 M | 52.9 M | 53 M | 56.7 M | 75 M | 64.2 M | 525 M | 1.22 B | 576 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 8.8 B | 10.4 B | 11.2 B | 14.6 B | 15.7 B | 2.07 B | 2.25 B | 2.28 B | 2.13 B | - | - | - | - | - |
Total Current Liabilities |
2.58 B | 2.45 B | 2.86 B | 2.36 B | 3.47 B | 2.56 B | 3.44 B | 2.42 B | 3.02 B | 2.38 B | 1.62 B | 1.04 B | 1.03 B | 866 M | 867 M | 702 M | 691 M | 771 M | - | - |
Total Liabilities |
10.4 B | 8.89 B | 9.01 B | 9.04 B | 10.8 B | 12.2 M | 12.2 B | 12.9 B | 14.2 B | 17 B | 17.3 B | 3.11 B | 3.28 B | 3.15 B | 3 B | 2.23 B | 2.15 B | 1.59 B | - | - |
Retained Earnings |
11.6 B | 11.1 B | 10.4 B | 9.56 B | 10.3 B | 10.1 M | 10.4 B | 9.49 B | 10 B | 8.47 B | 8.35 B | 8.29 B | 7.71 B | 7.09 B | 6.43 B | 5.7 B | 5.1 B | 4.39 B | - | - |
Total Assets |
23.1 B | 21.4 B | 21.5 B | 21.1 B | 23.5 B | 24.4 M | 24.6 B | 24.1 B | 26 B | 26.7 B | 27.2 B | 9.63 B | 9.58 B | 9.01 B | 8.52 B | 8 B | 7.79 B | 7.24 B | - | - |
Cash and Cash Equivalents |
592 M | 526 M | 416 M | 376 M | 378 M | 802 M | 618 M | 543 M | 524 M | 634 M | 1.46 B | 1.08 B | 1.08 B | 884 M | 768 M | 669 M | 692 M | 213 M | 464 M | 266 M |
Book Value |
12.7 B | 12.5 B | 12.5 B | 12 B | 12.7 B | 12.2 M | 12.4 B | 11.3 B | 11.7 B | 9.67 B | 9.89 B | 6.52 B | 6.3 B | 5.87 B | 5.51 B | 5.77 B | 5.64 B | 5.65 B | - | - |
Total Shareholders Equity |
12.7 B | 12.5 B | 12.5 B | 12 B | 12.7 B | 12.2 B | 12.4 B | 11.3 B | 11.7 B | 9.67 B | 9.89 B | 6.52 B | 6.3 B | 5.86 B | 5.51 B | 5.77 B | 5.64 B | 5.65 B | 5.45 B | 4.92 B |
All numbers in USD currency
Quarterly Balance Sheet Zimmer Biomet Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
6.3 B | 7.51 B | 6.75 B | 6.58 B | 4.74 B | 3.96 B | 4.83 B | 5.13 B | 5.19 B | 5.2 B | 5.15 B | 5.06 B | - | 5.29 B | 5.46 B | 6.46 B | 6.8 B | 5.46 B | 7.63 B | 7.63 B | 7.63 B | 7.63 B | 6.72 B | 6.72 B | 6.72 B | 6.72 B | 8.41 B | 8.41 B | 8.41 B | 8.41 B | 8.92 B | 8.92 B | 8.92 B | 8.92 B | 10.7 B | 10.7 B | 10.7 B | 10.7 B | 11.5 B | 11.5 B | 11.5 B | 11.5 B | 1.43 B | 1.43 B | 1.43 B | 1.43 B | 1.67 B | 1.67 B | 1.67 B | 1.67 B | 1.72 B | 1.72 B | 1.72 B | 1.72 B | 1.58 B | 1.58 B | 1.58 B | 1.58 B | 1.14 B | 1.13 B | 1.13 B | - | - |
Total Liabilities |
10 B | 10.7 B | 10.3 B | 9.78 B | 9.34 B | 8.77 B | 8.85 B | 8.7 B | 8.92 B | 9.09 B | 9.04 B | 9.08 B | - | 9.6 B | 10.8 B | 11.3 B | 11.6 B | 10.8 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.9 B | 12.9 B | 12.9 B | 12.9 B | 14.3 B | 14.3 B | 14.3 B | 14.3 B | 17 B | 17 B | 17 B | 17 B | 17.3 B | 17.3 B | 17.3 B | 17.3 B | 3.11 B | 3.11 B | 3.11 B | 3.11 B | 3.28 B | 3.28 B | 3.28 B | 3.28 B | 3.15 B | 3.15 B | 3.15 B | 3.15 B | 3 B | 3 B | 3 B | 3 B | 2.18 B | 2.09 B | 2.11 B | 1.67 B | 1.66 B |
Retained Earnings |
11.8 B | 11.5 B | 11.3 B | 11.2 B | 10.9 B | 10.7 B | 10.5 B | 10 B | 9.9 B | 9.74 B | 9.56 B | 9.74 B | - | 9.5 B | 10.3 B | 10.4 B | 10.3 B | 10.3 B | 10.1 B | 10.1 B | 10.1 B | 10.1 B | 10.4 B | 10.4 B | 10.4 B | 10.4 B | 9.49 B | 9.49 B | 9.49 B | 9.49 B | 10 B | 10 B | 10 B | 10 B | 8.47 B | 8.47 B | 8.47 B | 8.47 B | 8.35 B | 8.35 B | 8.35 B | 8.35 B | 8.36 B | 8.36 B | 8.29 B | 8.29 B | 7.71 B | 7.71 B | 7.71 B | 7.71 B | 7.09 B | 7.09 B | 7.09 B | 7.09 B | 6.43 B | 6.43 B | 6.43 B | 6.43 B | 5.66 B | 5.47 B | 5.31 B | 4.95 B | 4.8 B |
Total Assets |
22.7 B | 23.5 B | 22.9 B | 22.2 B | 21.7 B | 21.5 B | 21.5 B | 21.2 B | 21.3 B | 21.2 B | 21.1 B | 21.3 B | - | 21.6 B | 23.5 B | 24 B | 24.2 B | 23.5 B | 24.4 B | 24.4 B | 24.4 B | 24.4 B | 24.6 B | 24.6 B | 24.6 B | 24.6 B | 24.1 B | 24.1 B | 24.1 B | 24.1 B | 26 B | 26 B | 26 B | 26 B | 26.7 B | 26.7 B | 26.7 B | 26.7 B | 27.2 B | 27.2 B | 27.2 B | 27.2 B | 9.66 B | 9.66 B | 9.63 B | 9.63 B | 9.6 B | 9.58 B | 9.58 B | 9.58 B | 9.01 B | 9.01 B | 9.01 B | 9.01 B | 8.52 B | 8.52 B | 8.52 B | 8.52 B | 8 B | 7.83 B | 7.82 B | 7.65 B | 7.46 B |
Cash and Cash Equivalents |
424 M | 1.29 B | 557 M | 1.38 B | 569 M | 420 M | 393 M | 292 M | 320 M | 330 M | 376 M | 545 M | - | 436 M | 378 M | 920 M | 1.04 B | 378 M | 775 M | 802 M | 802 M | 802 M | 618 M | 618 M | 618 M | 618 M | 543 M | 543 M | 543 M | 543 M | 524 M | 524 M | 524 M | 524 M | 634 M | 634 M | 634 M | 634 M | 1.46 B | 1.46 B | 1.46 B | 1.46 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 1.08 B | 884 M | 884 M | 884 M | 884 M | 768 M | 768 M | 768 M | 768 M | 919 M | 954 M | 821 M | 440 M | 278 M |
Book Value |
12.7 B | 12.8 B | 12.5 B | 12.4 B | 12.4 B | 12.7 B | 12.6 B | 12.5 B | 12.4 B | 12.2 B | 12 B | 12.3 B | - | 12 B | 12.7 B | 12.7 B | 12.6 B | 12.7 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.4 B | 12.4 B | 12.4 B | 12.4 B | 11.3 B | 11.3 B | 11.3 B | 11.3 B | 11.7 B | 11.7 B | 11.7 B | 11.7 B | 9.67 B | 9.67 B | 9.67 B | 9.67 B | 9.89 B | 9.89 B | 9.89 B | 9.89 B | 6.55 B | 6.55 B | 6.52 B | 6.52 B | 6.31 B | 6.3 B | 6.3 B | 6.3 B | 5.87 B | 5.87 B | 5.87 B | 5.87 B | 5.51 B | 5.51 B | 5.51 B | 5.51 B | 5.82 B | 5.73 B | 5.71 B | 5.98 B | 5.81 B |
Total Shareholders Equity |
12.7 B | 12.8 B | 12.5 B | 12.4 B | 12.4 B | 12.7 B | 12.6 B | 12.5 B | 12.4 B | 12.2 B | 12 B | 12.3 B | 12.1 B | 12 B | 12.7 B | 12.7 B | 12.6 B | 12.7 B | 12.2 B | 12.2 B | 12.2 B | 12.2 B | 12.4 B | 12.4 B | 12.4 B | 12.4 B | 11.3 B | 11.3 B | 11.3 B | 11.3 B | 11.7 B | 11.7 B | 11.7 B | 11.7 B | 9.67 B | 9.67 B | 9.67 B | 9.67 B | 9.89 B | 9.89 B | 9.89 B | 9.89 B | 6.55 B | 6.55 B | 6.52 B | 6.52 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 5.86 B | 5.86 B | 5.86 B | 5.86 B | 5.51 B | 5.51 B | 5.51 B | 5.51 B | 5.82 B | 5.73 B | 5.71 B | 5.98 B | 5.81 B |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Zimmer Biomet Holdings, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
France
China
Canada
Australia
Britain
Israel
